Asia
TauRx analyzed the relationship between the treatment doses, blood levels and pharmacological activity of the drug on the brain in more than 1,000 patients with mild-to-moderate Alzheimer’s disease as part of two Phase III global clinical trials.
CGuard™ EPS clinical data featured as a prominent discussion point in multiple key presentations
Beyond Air, Inc. announced an exclusive five-year global supply agreement for NO and NO2 calibration gas with MESA Specialty Gases & Equipment.
BioLineRx Ltd., a clinical-stage biopharmaceutical company focused on oncology, announced that it will host an investor breakfast meeting on Thursday, December 5, 2019 at the Convene Conference Center near Grand Central Terminal in New York, N.Y.
The collaboration will use Image Processing and Artificial Intelligence/Machine Learning to revolutionise pathology practice and provide more precise cancer diagnostic assays
The approval marks the first time a Korean company independently brought a drug from discovery to FDA approval.
Tomocube Holotomography Microscopy enables Label-free, Non-invasive Study of individual Spermatozoon
Rapid 3D imaging and in-depth structural analysis opens up quality monitoring and spermatozoa selection for artificial insemination in humans and animals
STA Pharmaceutical Co., Ltd., – a subsidiary of WuXi AppTec – and Impact Therapeutics, a biotech focused on innovative drug discovery and development in anti-cancer therapeutics, announce the signing of a strategic partnership agreement.
The AP report shows that in China, Mundipharma representatives are informing doctors that OxyContin is less addictive than other painkillers, which is a similar tactic the company used in the 1990s in the United States.
Mayo Clinic and Hitachi, Ltd. have reached an agreement in principle to build a carbon ion treatment facility as part of Mayo Clinic’s recently announced integrated oncology facility which will be constructed at Mayo Clinic’s campus in Jacksonville, Florida.
PRESS RELEASES